Alpha Healthcare Acquisition Corp. License Agreements
10 Contracts & Agreements
- Sixth Amendment to Exclusive Patent License Agreement, dated January 10, 2022, between Duke University and Humacyte Global, Inc (Filed With SEC on March 29, 2022)
- Fifth Amendment to Exclusive Patent License Agreement, dated December 31, 2019, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)
- Fourth Amendment to Exclusive Patent License Agreement, dated January 2, 2018, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)
- Third Amendment to Exclusive Patent License Agreement, dated June 26, 2015, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)
- Second Amendment to Exclusive Patent License Agreement, dated April 24, 2014, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)
- First Amendment to Exclusive Patent License Agreement, dated February 25, 2011, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)
- Exclusive Patent License Agreement, dated March 14, 2006, between Duke University and Humacyte, Inc (Filed With SEC on March 23, 2021)
- Exclusive License Agreement, dated August 25, 2019, by and between Yale University and Humacyte, Inc (Filed With SEC on March 23, 2021)
- Exclusive License Agreement, dated August 13, 2019, by and between Yale University and Humacyte, Inc (Filed With SEC on March 23, 2021)
- Exclusive License Agreement, dated February 25, 2014, by and between Yale University and Humacyte, Inc (Filed With SEC on March 23, 2021)
